Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEkf Diagnostics Regulatory News (EKF)

Share Price Information for Ekf Diagnostics (EKF)

Share Price is delayed by 15 minutes
Get Live Data
26.80    -0.20 (-0.74%)
Bid:
26.50
Ask:
26.90
Spread: 0.40 (1.509%)
Market Cap: £115.31m
EKF Live PriceLast checked at - London Stock Exchange

Intraday Ekf Diagnostics Share Chart

Director Share Transfer

18 Jun 2013 10:17

RNS Number : 2824H
EKF Diagnostics Holdings PLC
18 June 2013
 



 

EKF Diagnostics Holdings plc

("EKF" or the "Company" or the "Group")

 

Director Share Transfer

 

EKF Diagnostics Holdings plc (AIM: EKF), the growing in-vitro diagnostics company, announces that it received notification on 17 June 2013 from Adam Reynolds, Non-Executive Director of EKF, that he has transferred 100,000 shares of one pence each ("Ordinary Shares") to his daughter as a gift. The transfer took place on 17 June 2013. Adam Reynolds' beneficial interest in the Company following this notification is now 3,176,153 Ordinary Shares, representing 1.16 per cent of the Company's issued share capital.

 

 

Enquiries:

 

EKF Diagnostics Holdings plc

Tel: 029 2071 0570

 

David Evans, Executive Chairman

Mob: 07740 084 452

 

Julian Baines, CEO

Mob: 07788 420 859

 

 

 

Canaccord Genuity Limited

Lucy Tilley / Henry Fitzgerald-O'Connor / Julian Feneley

Tel: 020 7523 8000

 

Walbrook PR Limited

Tel: 020 7933 8780

 

Paul McManus

Mob: 07980 541 893 or paul.mcmanus@walbrookpr.com

 

Paul Cornelius

Mob: 07866 384 707 or paul.cornelius@walbrookpr.com

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSSFMSUAFDSEFM
Date   Source Headline
16th Dec 20251:57 pmRNSShare Buyback
16th Dec 20257:00 amRNSExecutive Chair share purchase
8th Dec 20257:00 amRNSCancellation of Treasury Shares & TVR
24th Nov 202511:47 amRNSShare Buyback
19th Nov 20253:41 pmRNSShare Buyback
17th Nov 20252:12 pmRNSShare Buyback
4th Nov 20251:54 pmRNSTotal Voting Rights
3rd Nov 202510:19 amRNSShare Buyback
31st Oct 20251:02 pmRNSShare Buyback
30th Oct 202512:55 pmRNSShare Buyback
29th Oct 202510:59 amRNSShare Buyback
28th Oct 202511:00 amRNSShare Buyback
27th Oct 202510:25 amRNSShare Buyback
24th Oct 202511:10 amRNSShare Buyback
23rd Oct 202510:10 amRNSShare Buyback
21st Oct 20253:10 pmRNSShare Buyback & Extension of Buyback Programme
20th Oct 202512:24 pmRNSShare Buyback (Replacement)
20th Oct 202511:36 amRNSShare Buyback
17th Oct 20257:00 amRNSShare Buyback
15th Oct 202512:30 pmRNSShare Buyback
19th Sep 20254:25 pmRNSHolding(s) in Company
16th Sep 20257:15 amRNSLong Term Incentive Plan
16th Sep 20257:00 amRNSHalf-year Report
10th Sep 20257:00 amRNSNotice of interim results
26th Aug 20257:00 amRNSHematology contracts signed worth EUR 4.65m
28th Jul 20257:00 amRNSH1 2025 Trading Update
25th Jun 202512:00 pmRNSCancellation of Treasury Shares & TVR
17th Jun 20255:24 pmRNSHolding(s) in Company
2nd Jun 20257:00 amRNSTotal Voting Rights
21st May 20257:00 amRNSAdditional Share Buyback Programme
20th May 20252:41 pmRNSResult of AGM and Voting Results
20th May 20257:00 amRNSAGM Statement
13th May 20257:00 amRNSShare Buyback & Completion of Share Buyback Prog.
9th May 20251:42 pmRNSShare Buyback
8th May 20259:11 amRNSShare Buyback
6th May 20253:55 pmRNSShare Buyback
29th Apr 20257:00 amRNSShare Buyback
28th Apr 20257:00 amRNSPosting of AR&A & Notice of AGM
9th Apr 20257:00 amRNSShare Buyback
8th Apr 20257:00 amRNSShare Buyback
7th Apr 20252:58 pmRNSShare Buyback
7th Apr 20257:00 amRNSShare Buyback
2nd Apr 20257:00 amRNSShare Buyback
1st Apr 20257:00 amRNSShare Buyback
26th Mar 20257:00 amRNSDirector/PDMR Shareholding
25th Mar 20257:00 amRNSAppointment of CEO
25th Mar 20257:00 amRNSFull year results
6th Mar 20257:00 amRNSNotice of Results & Investor Presentations
7th Feb 20253:04 pmRNSHolding(s) in Company
6th Feb 202511:34 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.